CA-based Clerk secures $30million in series B round funding. This round was led by CRV, with participation from Stripe, and existing investors Andreessen Horowitz...
R.I.-based Bolden Therapeutics, Inc. secures $1.5M in pre-seed convertible note funding. This financing provides important support to enable Bolden to advance its preclinical development...
MA-based MitoSense secures $3.5million in seed funding. Lead the funding round was Caydan Capital Partners. The funding will be used by the company to...
Mercor, a California-based company, secures $3.6 million. Leading the round was General Catalyst, with participation from Soma Capital, Link Ventures, 2 | Twelve Angels,...
WA-based Avante secures $10m in seed funding. This round was led by Bellevue WA-based FUSE, with participation from Ascend Venture Capital, Highsage and a...
VA-based Deltek Acquired ProPricer. ProPricer, a Temecula, California-based supplier of a proposal pricing solution for government contractors and government agencies.
Read also - KY-based CSI...
Moonwalk Biosciences, a genomic medicine company pioneering precision epigenetic medicines announced the completion of $57 million in seed and Series A financing from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures. The financing will support continued advancement of Moonwalk’s epigenetic profiling and engineering technology platform and progress its pipeline of epigenetic therapeutics towards the clinic.
Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), announced the closing of a $95 million Series B financing led by new investor Alpha Wave Global. Viking Global Investors and Arkin Bio Capital participated in the financing, as well as existing investors Jeito Capital and ARCH Venture Partners.
Cambridge-based Remix Therapeutics secures $60M in funding. Remix Therapeutics (Remix), a clinical stage biotechnology company developing small molecule therapies to modulate RNA processing and...
